Search company, investor...

Oy Jurilab

jurilab.com

Investors Count

8

Funding, Valuation & Revenue

1 Fundings

Oy Jurilab's latest funding round was a Other Investors for on .

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

Other Investors

0

FY undefined

Date

Round

Other Investors

Amount

Investors

Valuation

Revenue

0

FY undefined

Sources

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Oy Jurilab Investors

8 Investors

Oy Jurilab has 8 investors. Sampo invested in Oy Jurilab's Other Investors funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1
Other Investors

Holding Company

Finland

Nanogen

Subscribe to see more

Corporation

California

DSM Venturing

Subscribe to see more

Corporate Venture

Netherlands

Tekes

Subscribe to see more

Public-Private Partnership

Finland

Sentica Partners

Subscribe to see more

Private Equity

Finland

First funding

Last Funding

Investor

Nanogen

DSM Venturing

Tekes

Sentica Partners

Rounds

1
Other Investors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Corporation

Corporate Venture

Public-Private Partnership

Private Equity

Location

Finland

California

Netherlands

Finland

Finland

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.